Hasan Rizvi
Bloomfield, NJ (USA)
Role(s):
VP/SVP/Dept Head
Healthxcel
Find More Startups
Startup
Location:
Bloomfield
Industry:
Pharmaceuticals
Year Founded:
2005
Number Employees:
10-50 people
Business Stage:
Growth (profitable)
Entity Type:
"S" Corporation
Description:
Prior to 2010, Healthxcel Corp was a service company oriented to servicing the practice organization needs of physicians across the eastern USA. In late 2009, as a result of some strategic planning processes, the decision was taken to orient refocus Healthxcel Corp towards a business acquisition and management role utilizing the skills of two new industry experts,both senior pharmaceutical executives, each with significant experience in brand, generic, OTC and natural health product companies, acquire and create synergies between acquired companies from around the world.
The established or previous management of Healthxcel is well connected into various financial investment groups around the world. The management has now re focused the business as follows: first, to acquire a generic drug manufacturing and distribution company, which is under-performing against its potential i.e. yet to reach its sales and marketing potential. The company has identified an acquisition target which under it's new management would multiply its sales significantly and thereby create a significant return on investment for its investors.
As detailed in the business plan, these enhanced results will come from the planned realignment of the business strategy and tactical execution coupled with an expansion to the product mix made available through the contacts of the new management team. The management team also expects to be able to expand the export volume of the company significantly.
In the second stage of its plan, the company is planning to secure both an Indian firm as well as a Middle-East based company in much the same fashion as the Argentina company.
The Healthxcel management has good connections and representation in Middle-Eastern countries, which will contribute to a successful business venture there as well.
Through contacts and sources we are tying the various components together, based upon the business plan of acquiring several healthcare assets in various places around the world and cross pollinating the products/services from each of these assets with the other units thereby taking advantage of the fixed investments in these assets to expand the marketing capabilities of these individual companies.
We are a group of experienced pharmaceutical professionals with extensive background, insight and networks in all segments of the pharmaceutical industry (brand, generic, OTC, nutraceuticals, medical devices etc…), to create a new vibrant and strategic firm with a global reach, to amply capitalize on the various upcoming changes in the industry including the blockbuster drugs that are going off patent in the next 3 to 5 years. Taking advantage of our background and understanding we are embarking upon various opportunities to create a global firm that will be a leader in the industry.